Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT06282250
Eligibility Criteria:
Inclusion Criteria:
* Must be bound to start the early intervention treatment being evaluated
* Aged 16-35, or \> 35 by indication of the patients' treating clinician
* Found to be at risk for SMI, as determined by the Early Detection and Intervention Team of GGzE
* Sufficient knowledge of Dutch or English language
* Ability to give informed consent
* Willing to complete daily monitoring throughout the duration of the study
Exclusion Criteria:
* Learningdifficulties,organicbraindiseaseorsevereneurologicalimpairment.
* Previously received BLT (less than 3 weeks prior to study entry
* Current severe substance or alcohol misuse (clinicians' assessment)
* In case of BLT: eye problems contraindicating BLT and/or being unable to visit the GGzE
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
35 Years
Study:
NCT06282250
Study Brief:
Protocol Section:
NCT06282250